Vikram Chandra on 2nd Covid vaccine entering fray, & other stories

Based on the success of early results in phase 3 clinical trials, Moderna has announced that its Covid vaccine candidate mRNA-1273 has shown a success rate of 95% in human trials. A much-needed glimmer of hope as the world braces through Covid? Latest stories with Vikram Chandra